EYPT (STOCKS)
EyePoint, Inc. Common Stock
$14.600000
+0.410000 (+2.89%)
Prev close: $14.190000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jay S. Duker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,211.43M
- Employees
- 144
- P/E (TTM)
- -4.59
- P/B (TTM)
- 3.84
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.81 | $-0.76 | -0.0473 | -6.20% |
|
Sep 2025 (Q3)
|
$-0.85 | $-0.80 | -0.0495 | -6.18% |
|
Jun 2025 (Q2)
|
$-0.85 | $-0.81 | -0.0370 | -4.55% |
|
Mar 2025 (Q1)
|
$-0.65 | $-0.67 | +0.0186 | +2.78% |
Financial Statements
| Revenues | $31.37M |
| Benefits Costs and Expenses | $263.05M |
| Costs And Expenses | $263.05M |
| Nonoperating Income/Loss | $11.75M |
| Operating Expenses | $274.81M |
| Depreciation and Amortization | $2.31M |
| Research and Development | $221.04M |
| Other Operating Expenses | $51.46M |
| Operating Income/Loss | -$243.43M |
| Income/Loss From Continuing Operations After Tax | -$231.96M |
| Income/Loss From Continuing Operations Before Tax | -$231.68M |
| Income Tax Expense/Benefit | $279.00K |
| Income Tax Expense/Benefit, Deferred | $279.00K |
| Net Income/Loss | -$231.96M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$231.96M |
| Net Income/Loss Available To Common Stockholders, Basic | -$231.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.17 |
| Diluted Earnings Per Share | -$3.17 |
| Basic Average Shares | 73,251 |
| Diluted Average Shares | 73,251 |
| Assets | $364.00M |
| Current Assets | $328.66M |
| Cash | $306.10M |
| Inventory | $1.81M |
| Prepaid Expenses | $3.52M |
| Other Current Assets | $17.23M |
| Noncurrent Assets | $35.34M |
| Fixed Assets | $9.02M |
| Other Non-current Assets | $26.32M |
| Liabilities | $57.88M |
| Current Liabilities | $37.02M |
| Accounts Payable | $10.49M |
| Wages | $14.53M |
| Other Current Liabilities | $12.00M |
| Noncurrent Liabilities | $20.86M |
| Equity | $306.11M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $306.11M |
| Liabilities And Equity | $364.00M |
| Net Cash Flow From Operating Activities | -$240.11M |
| Net Cash Flow From Operating Activities, Continuing | -$240.11M |
| Net Cash Flow From Investing Activities | $68.58M |
| Net Cash Flow From Investing Activities, Continuing | $68.58M |
| Net Cash Flow From Financing Activities | $173.65M |
| Net Cash Flow From Financing Activities, Continuing | $173.65M |
| Net Cash Flow | $2.12M |
| Net Cash Flow, Continuing | $2.12M |
| Comprehensive Income/Loss | -$232.03M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$232.03M |
| Other Comprehensive Income/Loss | -$67.00K |